Wellcome Leap Commercial Research Funding Agreement - Additional Information (Details) - Wellcome Leap Agreement - USD ($) $ in Millions	1 Months Ended	9 Months Ended
Jun. 30, 2024	Sep. 30, 2023	Sep. 30, 2024
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Grant funds payment received		$ 3.3
Return of unused grant funds received	$ 2.4
Commercial research funding agreement termination date			May 31, 2024

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483041/730-20-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483041/730-20-50-1

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration